<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 08 Nov 2009 12:26:01 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Notable Bankruptcies Of 2009: Q3</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3527406</guid>
      <description><![CDATA[In January I predicted (see Notable Bankruptcies of 2009: Q1) that “major” bankruptcies in 2009 would challenge the 383 mark set in 2001 (the high-water mark after the dotcom bubble). I even suggested that it was possible that we could exceed 400 “major” bankruptcies in 2009.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3527406>[More...]</a>]]></description>
      <pubDate>Mon, 05 Oct 2009 13:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ARG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AVR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BGM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BKUNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAPE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CCOW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CHTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COOP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBHI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FLE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IAR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ION</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JRC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LEA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LYO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MECA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MWY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NZT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SBKC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SGIC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SIX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SORC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSCC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STBC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TARR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TFIN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TMA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VEXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VNBC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">YBTVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3527406</link>
    </item>
    <item>
      <title>Analyst Comments: ENSCO, Cosan, Eli Lilly, Research In Motion, Internap Network, PetroChina, Kinross Gold, HEICO, Canadian Pacific, AutoNation, Oscient Pharma, Equity Residential, Supertex</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2672220</guid>
      <description><![CDATA[Dallas-based ENSCO International, Inc. (ESV) is a leading supplier of offshore contract drilling services to the oil and gas industry. The company's drilling fleet consists of 44 jackup rigs, two ultra-deepwater semi-submersible rigs (ENSCO 7500 and ENSCO 8500), and one barge rig. Additionally, the company has six ultra-deepwater semi-submersible rigs (ENSCO 8500 series) under construction.      ENSCO shares have been beaten down in recent days, broadly inline with its peer group, in response to the commodity-price weakness and overall market turmoil. The stock is down roughly 20% in the last four weeks alone, only modestly better than the 22% drop for offshore drillers (the S&amp;P 500 pulled back roughly 15% during the same time period.       While we have liked this name all along, we think that valuation has become even more compelling<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2672220>[More...]</a>]]></description>
      <pubDate>Thu, 02 Oct 2008 16:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CZZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EQR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HEI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INAP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KGC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2672220</link>
    </item>
    <item>
      <title>MiddleBrook Fall Could Mean Opportunity</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2465318</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2465318>[More...]</a>]]></description>
      <pubDate>Fri, 01 Aug 2008 20:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MBRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2465318</link>
    </item>
    <item>
      <title>Analyst Comments: Vimpel, Magna, NewAlliance, Omnicom, Oscient Pharma, Robert Half, Penske</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2300144</guid>
      <description><![CDATA[Vimpel-Communications (VIP) is the second largest cellular carrier in Russia. Robust subscriber growth and acquisitions continue to drive revenue and earnings momentum. Growth prospects in Eastern Europe for wireless services remain firm and support our forecast for strengthening financials. &lt;br...<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2300144>[More...]</a>]]></description>
      <pubDate>Thu, 19 Jun 2008 17:18:22 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MBT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MGA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NAL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OMC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RHI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VIP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2300144</link>
    </item>
    <item>
      <title>Analyst Comments: Smith Micro, ValueClick, Cox Radio, Churchill Downs, NCR Corp, Myriad Genetics, Oscient Pharma</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1854503</guid>
      <description><![CDATA[Smith Micro (SMSI) is a developer of wireless communications software and utility software for multiple OS platforms. It has significant relationships with several large cellular providers and OEM cell phone manufacturers.  First quarter results were in line with our expectations and we are not changing our forecasts for 2008 and 2009. The company announced a (potentially)...<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1854503>[More...]</a>]]></description>
      <pubDate>Thu, 08 May 2008 18:25:37 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CHDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CXR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QCOM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">S</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SMSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SYMC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VCLK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1854503</link>
    </item>
    <item>
      <title>Analyst Comments: Lockheed Martin, Consolidated Graphics, Analog Devices, Corel, Analog Devices, Oscient Pharma, LoopNet, Broadcom</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1690686</guid>
      <description><![CDATA[Lockheed Martin Corporation (LMT) appears well positioned to continue to benefit from strong defense outlays through 2008-09, debt repayment, and an ongoing share repurchase program since October 2002. Solid operating results via existing and new contracts -- both domestic and international -- coupled with the success of its C-130J and F-35 aircraft continue to deliver strong earnings and cash flow growth.  Management increased its...<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1690686>[More...]</a>]]></description>
      <pubDate>Fri, 04 Apr 2008 20:52:58 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BRCM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CGX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CREL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LMT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LOOP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RRD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VZ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1690686</link>
    </item>
    <item>
      <title>Analyst Comments: Oscient Pharmaceuticals, First Advantage, AmSurg, Anadys Pharmaceuticals, Dover Corp, Journal Register, Corel Corporation</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1462561</guid>
      <description><![CDATA[We maintain our Hold rating on shares of First Advantage Corporation (FADV) following the release of Q4 financial results. We believe the shares of FADV are appropriately valued near current levels. The shares of FADV are currently trading at a P/E multip<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1462561>[More...]</a>]]></description>
      <pubDate>Thu, 21 Feb 2008 19:45:13 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CPE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FADV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRAK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1462561</link>
    </item>
    <item>
      <title>Morning Earnings Summary</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1352934</guid>
      <description><![CDATA[Ticker Symbol: TTG,MGAM,GLG,ITT,PDX,XRAY,AHG,ALVR,ATMI,AVGN,BCE,BIIB,CACH,CI,CINF,DFZ,DVN,DWSN,ENB,HNI,IACI,KFRC,KIM,LFUS,LII,MAG,MKTX,MNC,NJR,NOV,NUCO,NUS,PXD,RAH,RAIL,RL,RSG,SBGI,SE,SLE,SON,TEL,TMO,TSEM,TWC,TWX,WXS,YDNT,DRRX,LNT,MMS,MNI,RTIX,SLH,WMG,NSR<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1352934>[More...]</a>]]></description>
      <pubDate>Wed, 06 Feb 2008 17:04:05 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AHG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALVR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ATMI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AVGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CACH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CINF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DFZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DRRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DVN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DWSN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ENB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IACI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ITT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFRC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KIM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFUS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LII</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LNT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MAG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MGAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MKTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NJR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NSR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NUCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NUS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POWL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PXD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RAH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RAIL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RSG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RTIX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SBGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TMO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TSEM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TTG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WXS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XRAY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">YDNT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1352934</link>
    </item>
    <item>
      <title>Analyst Comments: BASF Aktiengesellschaft, Allscripts Healthcare, Amphenol, Meredith, Amicus Therapeutics, Oscient Pharmaceuticals, Acergy S.A., I-Flow</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1244766</guid>
      <description><![CDATA[Zacks senior chemical industry analyst Paul Raman, CFA has maintained his Buy rating to Ludwigshafen, Germany-based chemical giant BASF Aktiengesellschaft (BASFY) in his latest report on the company. We excerpted the following details:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1244766>[More...]</a>]]></description>
      <pubDate>Mon, 21 Jan 2008 14:14:59 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACGY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">APH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BASFY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FOLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IFLO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SHPGY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1244766</link>
    </item>
    <item>
      <title>Analyst Comments: SanDisk, Joy Global, Ferrellgas Partners, Oscient Pharmaceuticals, Aladdin</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/1108037</guid>
      <description><![CDATA[Another update has been issued today on SanDisk Corporation (SNDK), in which Zacks senior manufacturing sector analyst Steve Biggs, CFA maintains his Buy rating on the computer hardware manufacturer albeit with a lower target price.&#160; Here we bring you some of the details:'SanDisk had struggled earlier in the year with rapid price declines in the flash market. However, growing demand for high-capacity...<a href=http://www.istockanalyst.com/article/viewarticle/articleid/1108037>[More...]</a>]]></description>
      <pubDate>Wed, 12 Dec 2007 20:34:17 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JOYG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNDK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/1108037</link>
    </item>
    <item>
      <title>Two New Products and Hoping for Cornerstone</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3459568</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 4--Cornerstone Therapeutics, which this month is adding two products that generated $46 million in annual sales last year, is on the prowl for other acquisitions. &lt;/li&gt;&lt;li&gt;That infrastructure includes its 100-person sales force. &lt;/li&gt;&lt;li&gt;On Thursday, Cornerstone received bankruptcy court approval to acquire the antibiotic Factive, which last year generated $16 million in sales, from Oscient Pharmaceuticals.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3459568>[More...]</a>]]></description>
      <pubDate>Fri, 04 Sep 2009 16:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3459568</link>
    </item>
    <item>
      <title>Oscient files for Chapter 11 bankruptcy protection</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3345913</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;WALTHAM, Mass. - Oscient Pharmaceuticals Corp. said Monday it has filed for Chapter 11 bankruptcy protection, and sold its chronic bronchitis drug Factive.&lt;/li&gt;&lt;li&gt;Oscient agreed to sell one of its two drugs, Factive, to Cornerstone Therapeutics Inc. for $5 million, plus royalties and the value of the drug's inventory.&lt;/li&gt;&lt;li&gt;Oscient said it expects its shares to be delisted from the Nasdaq on July 21.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3345913>[More...]</a>]]></description>
      <pubDate>Mon, 13 Jul 2009 22:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3345913</link>
    </item>
    <item>
      <title>Oscient Pharmaceuticals Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3345750</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oscient Pharmaceuticals Corporation (NASDAQ: OSCI) and its wholly owned   subsidiary, Guardian II Acquisition Corporation, today each filed a   voluntary petition for relief under Chapter11 of the United States   Bankruptcy Code in the United States Bankruptcy Court for the District   of Massachusetts. &lt;/li&gt;&lt;li&gt;Oscient and Guardian will continue to manage and   operate their businesses and assets during the pendency of the   bankruptcy case, subject to the supervision of the Bankruptcy Court.&lt;/li&gt;&lt;li&gt;In conjunction with the filing, Oscient and Guardian are seeking   customary authority from the Bankruptcy Court that will enable them to   continue operations and deliver products to customers in the ordinary   course of business and without interruption.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3345750>[More...]</a>]]></description>
      <pubDate>Mon, 13 Jul 2009 21:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3345750</link>
    </item>
    <item>
      <title>Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3345744</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;CARY, N.C., July 13  /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that it has signed a definitive asset purchase agreement with Oscient Pharmaceuticals Corporation (Nasdaq CM: OSCI) to acquire the commercial rights to the antibiotic Factive  (gemifloxacin mesylate) in North America and certain countries in Europe.  &lt;/li&gt;&lt;li&gt;Factive is a fluoroquinolone antibiotic approved for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB) and community-acquired pneumonia of mild to moderate severity (CAP).  &lt;/li&gt;&lt;li&gt;We believe that this product fits well within our existing portfolio and that our respiratory-focused sales force will be able to drive prescription growth of Factive in the U.S. market.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3345744>[More...]</a>]]></description>
      <pubDate>Mon, 13 Jul 2009 21:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRTX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3345744</link>
    </item>
    <item>
      <title>Oscient Pharmaceuticals Discontinues Sales Force Promotion for ANTARA and FACTIVE</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3266846</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oscient Pharmaceuticals Corporation (NASDAQ: OSCI) today announced that   it will discontinue sales force promotion of its two products: ANTARA&amp;#174;   (fenofibrate) capsules, a cardiovascular product and FACTIVE&amp;#174;   (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic.&lt;/li&gt;&lt;li&gt;Although direct selling efforts   will be discontinued, the Company intends to keep its products available   and on the market for physicians and their patients.&lt;/li&gt;&lt;li&gt;Oscient previously announced the engagement of Broadpoint Capital to   advise the Company on strategic options, including the potential sale of   the Company or its assets and that process is ongoing.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3266846>[More...]</a>]]></description>
      <pubDate>Thu, 11 Jun 2009 22:58:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3266846</link>
    </item>
    <item>
      <title>Oscient Pharmaceuticals Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3242301</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has received   notification from the Listings Qualifications Department of The NASDAQ   Stock Market LLC that since the Company has not filed its Form 10-Q for   the period ended March 31, 2009, the Company is no longer in compliance   with Marketplace Rule 5250(c)(1).&lt;/li&gt;&lt;li&gt;Following such submission, NASDAQ may provide   the Company with up to 180 calendar days from the filing's due date, or   until November 11, 2009, to regain compliance.&lt;/li&gt;&lt;li&gt;If NASDAQ does not accept the Company's plan to regain compliance, the   Company will receive written notification of delisting from NASDAQ and   at that time will be entitled to request a hearing before a NASDAQ   Listing Qualifications Panel to appeal the NASDAQ decision.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3242301>[More...]</a>]]></description>
      <pubDate>Fri, 22 May 2009 20:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3242301</link>
    </item>
    <item>
      <title>Oscient Pharmaceuticals Files Form 12b-25 Notification of Late Filing for Form 10-Q for Quarterly Period Ended March 31, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3302705</guid>
      <description><![CDATA[Oscient Pharmaceuticals Corporation (NASDAQ:OSCI) today announced that it cannot file on a timely basis its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2009, which was due to be filed with the Securities and Exchange Commission by May 15, 2009. The Company does not expect that such filing will be made within five calendar days of the due date, as required for the extension provided by Rule 12b-25(b) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3302705>[More...]</a>]]></description>
      <pubDate>Fri, 15 May 2009 20:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3302705</link>
    </item>
    <item>
      <title>Lazard Ltd Reports First-Quarter 2009 Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3209180</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Lazard Ltd (NYSE: LAZ) today announced financial results for the   first quarter ended March 31, 2009. &lt;/li&gt;&lt;li&gt;Net loss(c) on a fully   exchanged basis was $(29.7) million, or $(0.26) per share (diluted), for   the first quarter of 2009, excluding a previously announced $62.6   million pre-tax charge ($56.1 million after-tax) as a result of costs   related to staff reductions and realignments, compared to net income of   $16.0 million, or $0.14 per share (diluted), for the first quarter of   2008. &lt;/li&gt;&lt;li&gt;On a U.S. GAAP basis, which is before exchange of exchangeable interests   and includes the first-quarter pre-tax charge, the net loss was $(53.5)   million, or $(0.77) per share (diluted), for the first quarter of 2009,   compared to net income of $7.8 million or $0.14 per share (diluted) for   the first quarter of 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3209180>[More...]</a>]]></description>
      <pubDate>Tue, 28 Apr 2009 11:50:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ARIA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FTE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LAZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NRG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TWGP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRNM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3209180</link>
    </item>
    <item>
      <title>Oscient Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3146077</guid>
      <description><![CDATA[Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today reported financial results for the fourth quarter and fiscal year ended December 31, 2008. Total revenues for the fourth quarter of 2008 were $26.4 million, compared to $25.3 million in the fourth quarter of 2007. Revenue from the cardiovascular drug ANTARA&#174; (fenofibrate) capsules increased to $21.2 million in the fourth quarter of 2008, from $19.3 million in the fourth quarter of 2007. Revenues from the antibiotic FACTIVE&#174; (gemifloxacin mesylate) tablets decreased to $5.2 million in the fourth quarter of 2008, from $5.9 million in the fourth quarter of 2007.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3146077>[More...]</a>]]></description>
      <pubDate>Wed, 25 Mar 2009 12:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3146077</link>
    </item>
    <item>
      <title>Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3144865</guid>
      <description><![CDATA[Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial results for the fourth quarter and fiscal year ended December 31, 2008 on Thursday, March 26, 2009, prior to the opening of the U.S. financial markets. A conference call will be held at 8:30 a.m. Eastern Time.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3144865>[More...]</a>]]></description>
      <pubDate>Tue, 24 Mar 2009 23:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3144865</link>
    </item>
    <item>
      <title>NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Compliance Period Extended to October 6, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3142173</guid>
      <description><![CDATA[Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has received notification from NASDAQ OMX (“NASDAQ”) that, given the current extraordinary market conditions, NASDAQ has further extended the temporary suspension of the rules requiring a minimum market value of publicly held shares (“MVPHS”) and a minimum $1 closing bid price by 90 days.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3142173>[More...]</a>]]></description>
      <pubDate>Tue, 24 Mar 2009 11:26:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3142173</link>
    </item>
    <item>
      <title>Oscient Pharmaceuticals Restructures Commercial Organization</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3031824</guid>
      <description><![CDATA[Oscient Pharmaceuticals Corporation (NASDAQ: OSCI) today announced a strategic realignment of its commercial organization to more aggressively preserve the Company’s financial resources, while retaining coverage of those physicians with potential to generate the highest volume of prescriptions. In addition, Oscient has engaged Broadpoint Capital, Inc. (NASDAQ: BPSG) to advise the Company on strategic options, including the potential sale of the Company.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3031824>[More...]</a>]]></description>
      <pubDate>Wed, 11 Feb 2009 22:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3031824</link>
    </item>
    <item>
      <title>Form  3          BAB BIO VENTURES NV       For: Jan 28 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3250180</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3250180>[More...]</a>]]></description>
      <pubDate>Fri, 29 May 2009 22:10:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3250180</link>
    </item>
    <item>
      <title>Form  4          OSCIENT PHARMACEUTICALS   For: May 21  Filed by: GLG Partners LTD (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3245353</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3245353>[More...]</a>]]></description>
      <pubDate>Wed, 27 May 2009 02:23:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3245353</link>
    </item>
    <item>
      <title>Form  4          OSCIENT PHARMACEUTICALS   For: May 13  Filed by: DellaCamera Capital Management, LLC (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3234527</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3234527>[More...]</a>]]></description>
      <pubDate>Fri, 15 May 2009 22:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3234527</link>
    </item>
    <item>
      <title>Form  4          OSCIENT PHARMACEUTICALS   For: May 11  Filed by: DellaCamera Capital Management, LLC (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3231459</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3231459>[More...]</a>]]></description>
      <pubDate>Thu, 14 May 2009 00:42:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3231459</link>
    </item>
    <item>
      <title>Form  4          OSCIENT PHARMACEUTICALS   For: May 08  Filed by: DellaCamera Capital Management, LLC (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3229502</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3229502>[More...]</a>]]></description>
      <pubDate>Tue, 12 May 2009 23:36:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3229502</link>
    </item>
    <item>
      <title>Form  4          OSCIENT PHARMACEUTICALS   For: Apr 15  Filed by: DellaCamera Capital Management, LLC (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3198960</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3198960>[More...]</a>]]></description>
      <pubDate>Fri, 17 Apr 2009 23:00:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3198960</link>
    </item>
    <item>
      <title>Form  4          OSCIENT PHARMACEUTICALS   For: Mar 25  Filed by: DellaCamera Capital Management, LLC (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3154559</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3154559>[More...]</a>]]></description>
      <pubDate>Fri, 27 Mar 2009 22:18:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3154559</link>
    </item>
    <item>
      <title>Form  3          OSCIENT PHARMACEUTICALS   For: Nov 25  Filed by: GLG Market Neutral Fund (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2957539</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2957539>[More...]</a>]]></description>
      <pubDate>Thu, 15 Jan 2009 19:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2957539</link>
    </item>
    <item>
      <title>Form  4          Michael Kao               For: Nov 25 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2906238</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2906238>[More...]</a>]]></description>
      <pubDate>Wed, 24 Dec 2008 00:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2906238</link>
    </item>
    <item>
      <title>Form  3/A        OSCIENT PHARMACEUTICALS   For: Nov 25  Filed by: Michael Kao (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2891504</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2891504>[More...]</a>]]></description>
      <pubDate>Wed, 17 Dec 2008 22:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">OSCI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2891504</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=OSCI" rel="self" type="application/rss+xml" />
  </channel>
</rss>